UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024743
Receipt number R000028467
Scientific Title The analysis of mucosa-associated microbiota in IBD
Date of disclosure of the study information 2016/11/07
Last modified on 2017/06/19 15:11:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The analysis of mucosa-associated microbiota in IBD

Acronym

The analysis of mucosa-associated microbiota in IBD

Scientific Title

The analysis of mucosa-associated microbiota in IBD

Scientific Title:Acronym

The analysis of mucosa-associated microbiota in IBD

Region

Japan


Condition

Condition

inflammatory bowel disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the components of mucosa-associated in IBD

Basic objectives2

Others

Basic objectives -Others

To assess the impact of mucosa-associated microbiota on the pathology of IBD

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The components of mucosa-associated microbiota and the impact on the pathology of IBD

Key secondary outcomes

The association of mucosa-associated microbiota and treatment history


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

IBD patients who undergoing gastrointestinal endoscopy
Other patients who undergoing gastrointestinal endoscopy

Key exclusion criteria

Patients who reject to participate in this study
Patients with infectious disease that requires notification under the Infectious Diseases Control Law
Patients who are considered to be unsuitable to this study for any other reason

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Andoh

Organization

Shiga University of Medical Science

Division name

Division of Gastroenterology, Department of Medicine

Zip code


Address

Setatsukinowa, Otsu

TEL

077-548-2217

Email

andoh@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Nishida

Organization

Shiga University of Medical Science

Division name

Division of Gastroenterology, Department of Medicine

Zip code


Address

Setatsukinowa, Otsu

TEL

077-548-2217

Homepage URL


Email

atsuda@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga University of Medical Science

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 11 Month 07 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We aim to clarify the structure and function analysis of mucosa-associated microbiota in patients with inflammatory bowel disease.


Management information

Registered date

2016 Year 11 Month 07 Day

Last modified on

2017 Year 06 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028467


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name